ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Alarelin
C60H86N16O16
1287.4 g/mol
APIDanger

Ala(6)-gly(10)-gnrh

CAS79561-22-1
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

Ala(6)-gly(10)-gnrh is a synthetic peptide analog of gonadotropin-releasing hormone (GnRH) modified at positions 6 and 10 with alanine and glycine residues, respectively. It is supplied as an acetate salt and is used as a research compound in studies related to growth hormone agonistic activity.

growth hormone agonistic analogresearch reagent for peptide studies

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Ala(6)-gly(10)-gnrh?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongStructure SimilarSimilarity 0.92

6-D-ala-gonadorelin

CAS51230-19-4

pharmaceutical raw material

StrongStructure SimilarSimilarity 0.92

Fertirelin

CAS38234-21-8

pharmaceutical raw material

StrongStructure SimilarSimilarity 0.92

Fertirelin acetate

CAS66002-66-2

pharmaceutical raw material

ReferenceSame Category

Brimonidine tartrate

CAS79570-19-7

pharmaceutical raw material

ReferenceSame Category

Maytansinoid DM3

CAS796073-54-6

pharmaceutical raw material

ReferenceSame Category

Ravtansine

CAS796073-69-3

pharmaceutical raw material

ReferenceSame Category

Sertraline

CAS79617-96-2

pharmaceutical raw material

Referencestereoisomer of

Dalareline

CAS52435-06-0

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Health Hazard
Health Hazard
Danger
H360May damage fertility or the unborn child
Identifiers
IUPAC Name

acetic acid;N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide

InChIKey

DPWSRXJWCYEGIV-CWMZTGDLSA-N

SMILES

CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O.CC(=O)O

Synonyms (8)
  • LHRH-A
  • Ala(6)-gly(10)-gnrh
  • GnRHa cpd

Sourcing Ala(6)-gly(10)-gnrh?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→